• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

June 8, 2021

U.S. News & World Report and Pharmacy Times® Reveal 2021 Top-Recommended Health Products

Pharmacists' No. 1 picks include Children's Claritin and Tylenol.

U.S. News & World Report, the global authority in rankings and consumer advice, and Pharmacy Times®, the leading multimedia resource for pharmacy professionals, today released the top-recommended health products for 2021. Tylenol came in as the No. 1 pick among the surveyed pharmacists for treating headaches, and Claritin products topped the list for allergy relief in adults and children.

Now in its 25th year, the OTC Guide®, published by Pharmacy Times®, provides recommendations from pharmacists for more than 1,000 over-the-counter (OTC) brands across 152 product categories, 133 of which U.S. News also publishes. These results give pharmacists, patients and other health care professionals a trusted resource to promote wellness, prevent and treat acute ailments and illnesses and manage more complex conditions, leading to improved patient outcomes.

Pharmacies are not only accessible and conveniently located, but also are a trusted resource for patients suffering from both common and comorbid conditions. By providing critical services such as patient education, medication dispensing, vaccinations, recommendations for OTC medications and medication management, pharmacy teams continue to be essential. According to the Centers for Disease Control and Prevention, more than 90% of Americans live within five miles of a pharmacy, and patients visit their community pharmacy an average of 12 times more per year than their primary care physician.

As preventive care remains a high priority and COVID-19 vaccinations and CDC guidelines allow more Americans to begin traveling again, the top products can help consumers and their families stay healthy all year long. The No. 1 pharmacist-recommended brands include:

  • Headache: Tylenol
  • Cough suppressant: Delsym
  • Cold remedies: Cepacol
  • Flu products: Theraflu
  • Oral antihistamines: Claritin
  • Antibacterial soaps: Hibiclens
  • Multivitamin: Centrum
  • Sunscreen: Neutrogena
  • Pregnancy test: First Response
  • Hand sanitizers: Purell
  • Insect bite and sting management: After Bite
  • Eczema care/relief: CeraVe
  • Acne: Differin Gel

To keep children healthy year-round, the 2021 top-recommended health products for common ailments such as allergies, sore throat and cough include:

  • Children's allergy: Children's Claritin
  • Children's cough and cold: Children's Dimetapp
  • Children's analgesic: Children's Tylenol
  • Children's sore throat: Zarbee's Naturals

This year's picks feature at-home testing products, including Braun ThermoScan digital thermometer, OneTouch blood glucose monitors, Omron blood pressure monitors and First Check drug tests.

"As more Americans roll up their sleeves to receive the COVID-19 vaccine, and people begin to travel and return to the office, they're looking for easily accessible information about over-the-counter allergy, headache and pain medicine," said Kim Castro, editor and chief content officer at U.S. News. "The expertise of Pharmacy Times® combined with the in-depth journalism and analysis from U.S. News empowers consumers to research products for their affliction and, along with input from a physician or general practitioner, know that they made the most informed decision for their health."

Ed Cohen, Pharm.D., FAPhA, executive vice president of pharmacy advocacy for Pharmacy Times® added, "The OTC Guide® gives consumers everywhere insight into which over-the-counter products pharmacists know and recommend. Patients continue to turn to OTC products to treat their conditions and pharmacists continue to counsel and recommend appropriate OTC products. We are proud to be working with U.S. News once again to put together this comprehensive guide of pharmacist recommendations, and we are thankful for the time and effort pharmacists put into taking the survey, especially this year balancing their time with COVID-19 priorities."

U.S. News and Pharmacy Times® began collaborating in 2012 to bring pharmacist recommendations to consumers nationwide. Pharmacy Times® evaluates pharmacists' insights and preferences through an annual research program conducted by HRA® – Healthcare Research and Analytics, a consultative health care market research practice. Through U.S. News' Drugs & Treatments section, consumers have an easy and searchable way to access the information produced by pharmacists' recommendations. U.S. News displays brands that received at least 1% of pharmacists' votes but awards a No. 1 Pharmacist Recommended Brand designation only to the top-ranked product in each category.

For more information, visit Facebook or Twitter using #OTCGuide or go to otcguide.net to access the rankings and search pharmacist recommendations by symptom, product or category.

About U.S. News & World Report
U.S. News & World Report is the global leader in quality rankings that empower citizens, consumers, business leaders and policy officials to make better, more informed decisions about important issues affecting their lives. A multifaceted digital media company with Education, Health, Money, Travel, Cars, News and 360 Reviews platforms, U.S. News provides rankings, independent reporting, data journalism, consumer advice and U.S. News Live events. More than 40 million people visit USNews.com each month for research and guidance. Founded in 1933, U.S. News is headquartered in Washington, D.C.

About Pharmacy Times®
Pharmacy Times® is the industry-leading multimedia pharmacy network of community, health system, oncology, and specialty pharmacy platforms, providing practical clinical and professional information pharmacists can use in their everyday practices when counseling patients and interacting with other health care providers. Each issue and the website contain articles and features covering industry trends, drug interactions, patient education, disease state management, patient counseling, product news, pharmacy law, and more. Additionally, Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy Times® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

SOURCE U.S. News & World Report

Related Videos
Related Content
Advertisement
Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP
May 15th 2025

Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP

Camber Launches Eltrombopag PFOS & Tablets
May 14th 2025

Camber Launches Eltrombopag PFOS & Tablets

Camber Pharmaceuticals Announces Addition of Eslicarbazepine Acetate Tablets
May 7th 2025

Camber Pharmaceuticals Announces Addition of Eslicarbazepine Acetate Tablets

Camber Pharmaceuticals Announces Addition of Phenylephrine Hydrochloride Injection, USP
May 1st 2025

Camber Pharmaceuticals Announces Addition of Phenylephrine Hydrochloride Injection, USP

Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP
April 29th 2025

Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP

Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets
April 14th 2025

Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets

Related Content
Advertisement
Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP
May 15th 2025

Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP

Camber Launches Eltrombopag PFOS & Tablets
May 14th 2025

Camber Launches Eltrombopag PFOS & Tablets

Camber Pharmaceuticals Announces Addition of Eslicarbazepine Acetate Tablets
May 7th 2025

Camber Pharmaceuticals Announces Addition of Eslicarbazepine Acetate Tablets

Camber Pharmaceuticals Announces Addition of Phenylephrine Hydrochloride Injection, USP
May 1st 2025

Camber Pharmaceuticals Announces Addition of Phenylephrine Hydrochloride Injection, USP

Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP
April 29th 2025

Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP

Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets
April 14th 2025

Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets

Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.